CSF sTREM2 levels correlate with CSF levels of total tau (T-tau), a marker of neuronal injury, in AD cohorts, but generally not with β-amyloid 1–42 (Aβ42) levels [21, 22, 24–26]. Here, MAPT is linked to Alzheimer disease.